In urogenital gonorrhea, gepotidacin was noninferior to ceftriaxone + azithromycin for microbiological success. Anaekwe A, Brennan K, Glatt AE. Ann Intern Med 2025;178:JC88.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Anaekwe A, Brennan K, Glatt AE. In urogenital gonorrhea, gepotidacin was noninferior to ceftriaxone + azithromycin for microbiological success. Ann Intern Med 2025;178:JC88.
PMID: 40759023